Search results for: 'point pharmaceutical'

23 Jun 2016  |  North America  |  Market Research

Growth Opportunities in the US Point-of-care Testing Market

Digital Health Meets Point of Care—Emergence of Mobile Molecular Diagnostics

Infographics

×

The US point-of-care testing (POCT) study provides an extensive analysis for 13 segments: hematology, urinalysis, infectious disease, cardiac, HbA1c, glucose, fecal occult blood test/fecal immunochemical test (FOBT/FIT), coagulation PT/INR, coagulation APTT/ACT, cholesterol, pregnancy, drugs of abuse, and blood gas and electrolytes. Key trends and ...

The main objective of this research is to estimate test volumes and unit prices for a wide variety of LDTs (genetic) and a few high volume FDA tests for selective therapeutic areas. The tests are categorized by their intended uses across the diagnostic spectrum (risk assessment, screening, diagnosis, staging and prognosis, therapy selection, therap...

The COVID-19 pandemic has not only revealed supply chain challenges in terms of meeting pandemic-induced demand but also showcased weaknesses with regard to facing disruptions on a global scale. Immediate impacts include supply volatility, steep price increases, and high levels of uncertainty. Despite the manufacturing reboot, supply chain inter...

The Chinese pharmaceutical market is expected to be the third-largest in the world in 2013. This research service analyzes various aspects of the Chinese pharmaceutical market between 2007 and 2016. Rising income, improving healthcare infrastructure, and insurance systems are some factors that drive this market. The study discusses in detail the ma...

This study covers the pharmaceutical industry in key SADC countries, including Malawi, Mauritius and Zambia. The research service provides detailed metrics on the pharmaceutical industries, encompassing the OTC and prescription markets, as well as the branded and generic markets. The research examines drivers and restraints for growth, distribution...

This research service offers comprehensive discussions about the key approvals, mergers and acquisitions, product licensing deals, and digital partnerships of the pharmaceutical industry in 2022. A renewed focus on operational excellence and digital transformation will push top-line pharmaceutical industry growth and drive strong partnerships with ...

This research service presents the findings on the pharmaceutical market in Ethiopia. The research service presents an overview of the healthcare and pharmaceutical industry structure of the country. The market size and growth of the total Ethiopian pharmaceutical market, including six main therapeutic segments that characterize the prescription dr...

This research service presents findings on the pharmaceutical markets of six countries in sub-Saharan Africa, namely Botswana, Ghana, Kenya, Nigeria, Tanzania, and Zambia. The research service presents an overview of the healthcare structure of each country. Market size and growth of the total pharmaceutical market and six main therapeutic segments...

The pharma industry is one of the fastest growing industry sectors in India today, and the demand for APIs and intermediates in India is higher than ever. This research service talks about the Indian pharmaceutical intermediates market, focusing on top-selling therapy segments. It analyses the demand for intermediates in each segment, drivers, rest...